Name: Resistance to Targeted Therapies in Multiple Myeloma (en Inglés)
Price: 3601.07 MXN
Availability: InStock
Author: Ling, Silvia Cw ; Trieu, Steven
ISBN: 9783030734428

Envío gratis

portada Resistance to Targeted Therapies in Multiple Myeloma (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Ling, Silvia Cw ; Trieu, Steven

Idioma

Inglés

N° páginas

154

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 0.9 cm

Peso

0.25 kg.

ISBN13

9783030734428

Categorías

Oncología
Inmunología

Resistance to Targeted Therapies in Multiple Myeloma (en Inglés)

Ling, Silvia Cw ; Trieu, Steven (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 3,601.07

$ 6,001.78

Ahorras: $ 2,400.71

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 17 de Julio y el Jueves 25 de Julio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Resistance to Targeted Therapies in Multiple Myeloma (en Inglés)"

Multiple Myeloma remains an incurable malignancy. As the disease progresses, it invariably becomes resistant to treatment and almost all patients develop refractory disease. There are multiple different types of targeted therapies and many of them are used in combination at different stages of disease. Targeted therapies that are approved to be used include Proteasome Inhibitors, Immunomodulatory Drugs and Monoclonal Antibodies. Second and third generations of these drugs are developed to overcome resistance and they have unique mechanism of actions. Targeted therapies that are undergoing clinical trials include CAR-T cells, bi-specific antibodies, vaccines, ubiquitin ligase inhibitors and BCL-2 inhibitors. This book will help to develop an understanding of targeted therapies in Multiple Myeloma. Its goal is to provide a unique review of the mechanism of action and resistance of the many targeted therapies in Multiple Myeloma by leaders of the field. The book will be useful for students in medical science, clinicians, health professionals, scientists, pharmaceutical professionals, drug developers, and policy makers. This book will provide an insightful knowledge of the biology of Multiple Myeloma, the mechanism of action and resistance of targeted therapies, application of biomarkers and genomics and possible strategies in overcoming resistance and future development.